Copyright
©The Author(s) 2020.
World J Gastrointest Pharmacol Ther. Nov 8, 2020; 11(5): 93-109
Published online Nov 8, 2020. doi: 10.4292/wjgpt.v11.i5.93
Published online Nov 8, 2020. doi: 10.4292/wjgpt.v11.i5.93
Figure 1 At 7 d (7) or 14 d (14) post-injury, we assessed the adhesion score (0-4), min/med/max.
Medication (/kg), was BPC 157 [10 µg (µ) or 10 ng (n)] (b - 1 mL bath/rat at abdominal cavity, B – once daily intraperitoneally, first application at 30 min following surgery, last 24 h before sacrifice; B once daily intraperitoneally, first application at day 7 following surgery, last 24 h before sacrifice) or saline(controls)(C) (bath equal volume, or once daily intraperitoneally (since not different results are shown together). aP < 0.05 at least vs control.
- Citation: Berkopic Cesar L, Gojkovic S, Krezic I, Malekinusic D, Zizek H, Batelja Vuletic L, Petrovic A, Horvat Pavlov K, Drmic D, Kokot A, Vlainic J, Seiwerth S, Sikiric P. Bowel adhesion and therapy with the stable gastric pentadecapeptide BPC 157, L-NAME and L-arginine in rats. World J Gastrointest Pharmacol Ther 2020; 11(5): 93-109
- URL: https://www.wjgnet.com/2150-5349/full/v11/i5/93.htm
- DOI: https://dx.doi.org/10.4292/wjgpt.v11.i5.93